Navigation Links
Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
Date:1/23/2008

Access the Q1 earnings teleconference today at 10:00 a.m. EST by calling (719) 325-4826 and entering passcode 8101417, or listen on the Web at:

http://www.airproducts.com/Invest/financialnews/EarningsReleases.htm.

LEHIGH VALLEY, Pa., Jan. 23 /PRNewswire-FirstCall/ -- Air Products (NYSE: APD) today reported net income of $264 million, or diluted earnings per share (EPS) of $1.19, for its fiscal first quarter ended December 31, 2007. Net income increased 15 percent, and diluted EPS increased 16 percent compared with the prior year.

These results include $0.03 of discontinued operations related to a previously announced definitive agreement to divest Air Products' interest in its polymers joint ventures to Wacker Chemie AG and the completed sale of the company's High Purity Process Chemicals (HPPC) business to KMG Chemicals during the quarter. On a continuing operations basis, net income increased 16 percent, and diluted EPS increased 17 percent.

First quarter revenues of $2,474 million were up nine percent from the prior year on higher volumes, improved pricing across most segments, and a weaker dollar. Operating income of $372 million was up 17 percent versus the prior year.

John McGlade, president and chief executive officer, said, "Our fiscal year is off to a great start, thanks to the dedication and commitment of our 22,000 employees worldwide. We delivered double-digit earnings growth and significant margin improvement during the quarter. This strong performance reflects the continued emphasis we have placed on delivering profitable growth through our global focus and relentless drive for productivity." (47.0)

Other (30.1) (21.1)

Working capital changes that provided (used)

cash, excluding effects of acquisitions and

divestitures:

Trade receivables (77.4) (36.6)

Inventories (27.3) (16.0)

Contracts in progress 47.0 52.5

Prepaid expenses 47.0 6.1

Payables and accrued liabilities (85.9) (224.9)

Other 42.9 6.5

CASH PROVIDED BY OPERATING ACTIVITIES (a) 368.0 150.4

INVESTING ACTIVITIES FROM CONTINUING OPERATIONS

Additions to plant and equipment (b) (271.2) (232.1)

Acquisitions, less cash acquired (1.4) --

Investment in and advances to unconsolidated

affiliates -- (1.5)

Proceeds from sale of assets and investments 9.0 12.5

Proceeds from insurance settlements -- 14.9

Change in restricted cash (135.7) --

Other (.8) (.4)

CASH USED FOR INVESTING ACTIVITIES (400.1) (206.6)

FINANCING ACTIVITIES FROM CONTINUING OPERATIONS

Long-term debt proceeds 160.5 53.8

Payments on long-term debt (41.6) (36.2)

Net increase in commercial paper and short-term

borrowings 120.1 226.2

Dividends paid to shareholders (81.9) (73.9)

Purchase of Treasury Stock (189.7) (133.5)

Proceeds from stock option exercises 33.0 37.0

Excess tax benefit from share-based

compensation/other 21.5 6.7

CASH PROVIDED BY FINANCING ACTIVITIES 21.9 80.1

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(Unaudited)

(Millions of dollars)

Three Months Ended

31 December

2007 2006

DISCONTINUED OPERATIONS

Cash (used for) provided by operating activities (1.3) 9.0

Cash provided by (used for) investing activities 65.8 (6.2)

Cash used for financing activities -- --

CASH PROVIDED BY DISCONTINUED OPERATIONS 64.5 2.8

Effect of Exchange Rate Changes on Cash 1.7 (.4)

Increase in Cash and Cash Items 56.0 26.3

Cash and Cash Items - Beginning of Year 40.5 31.0

Cash and Cash Items - End of Period $96.5 $57.3

(a) Pension plan contributions in 2008 and 2007 were $69.8 and $239.9,

respectively.

(b) Excludes capital lease additions in 2008 and 2007 of $.7 and $.6,

respectively.

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Millions of dollars)

1. NEW ACCOUNTING STANDARD The Company adopted Financial Accounting Standards Board (FASB) Interpretation No. 48, "Accounting for Uncertainty in Income Taxes-an interpretation of FASB Statement No. 109," (FIN No. 48) on 1 October 2007. Upon adoption, the Company recognized a $25.5 increase to its liability for uncertain tax positions. This increase was recorded as an adjustment to beginning retained earnings for $13.7 and goodwill for $11.8.

2. DISCONTINUED OPERATIONS

The High Purity Process Chemicals (HPPC) business and the Polymer Emulsions business have been accounted for as discontinued operations. The results of operations and cash flows of these businesses have been removed from the results of continuing operations for all periods presented. The balance sheet items of discontinued operations have been reclassified and are segregated in the consolidated balance sheets.

HPPC Business

In September 2007, the Company's Board of Directors approved the sale of its HPPC business, which had previously been reported as part of the Electronics and Performance Materials operating segment. The Company's HPPC business consisted of the development, manufacture, and supply of high-purity process chemicals used in the fabrication of integrated circuits in the United States and Europe. The Company wrote down the assets of the HPPC business to net realizable value as of 30 September 2007, resulting in a loss of $15.3 ($9.3 after-tax, or $.04 per share) in the fourth quarter of 2007. In October 2007, the Company executed an agreement of sale with KMG Chemicals, Inc. The sale closed on 31 December 2007 for cash proceeds of $69.3 and included manufacturing facilities in the United States and Europe. Certain receivables and inventories will be sold to KMG Chemicals, Inc. subsequent to 31 December 2007. In the first quarter of 2008, this business generated sales of $22.9 and income, net of tax, of $.2. Also, the Company recorded an additional loss of $.5 ($.3 after-tax) on the sale of the business.

Polymer Emulsions Business

The Company announced it was exploring the sale of its Polymer Emulsions business in 2006 as part of the Company's ongoing portfolio management activities. In November 2007, the Company's Board of Directors granted the Company the authority to sell this business to its partner based on achieving certain contractual terms and conditions. On 11 December 2007, the Company announced it had signed a definitive agreement to sell its interest in its vinyl acetate ethylene (VAE) polymers joint ventures to Wacker Chemie AG, its long-time joint venture partner. As part of the agreement, the Company will receive Wacker Chemie AG's interest in the Elkton, Md., and Piedmont, S.C., production facilities and their related businesses plus cash considerations of $265. The sale, which is subject to regulatory approvals and customary closing conditions, is expected to close in the second quarter of fiscal year 2008. The Company anticipates a gain on the sale of the Polymer Emulsions business in the range of $65 to $85 ($42 to $55 after-tax).

In the first quarter of 2008, this business generated sales of $151.2 and income, net of tax, of $6.8.

The sale consists of the global VAE polymers operations including production facilities located in Calvert City, Ky.; South Brunswick, N.J.; Cologne, Germany; and Ulsan, Korea; and commercial and research capabilities in Allentown, Pa., and Burghausen, Germany. The business produces VAE for use in adhesives, paints and coatings, paper and carpet applications.

Upon completion of the sale, the Company will assume full ownership of the Elkton and Piedmont plants and related North American atmospheric emulsions and global pressure sensitive adhesives business. The Company intends to sell these businesses.

3. PENSION SETTLEMENT

A number of senior managers and others who were eligible for supplemental pension plan benefits retired in fiscal year 2007. The Company's supplemental pension plan provides for a lump sum benefit payment option at the time of retirement, or for corporate officers six months after the participant's retirement date. If payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the fiscal year, settlement accounting is triggered under pension accounting rules. However, a settlement loss may not be recognized until the time the pension obligation is settled. The Company recognized $10.3 for settlement losses in the fourth quarter of 2007 and an additional $1.4 in the first quarter of 2008, based on cash payments made. The Company expects to recognize an additional $25 to $30 for settlement losses in 2008, primarily in the second quarter. This additional charge pertains to 2007 and announced 2008 retirements. The actual amount of the settlement loss will be based upon current pension assumptions (e.g. discount rate) at the time cash payments are made to settle the obligations.

4. SHARE REPURCHASE PROGRAM

On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company's outstanding common stock. This action was in addition to an existing $1,500 share repurchase authorization which was announced in March 2006. As of 30 September 2007, the Company had purchased 5.0 million of its outstanding shares at a cost of $1,063.4 under these two authorizations. During the first quarter of fiscal year 2008, the Company purchased 2.0 million of its outstanding shares at a cost of $189.8. The Company will continue to purchase shares under these authorizations at its discretion while maintaining sufficient funds for investing in its businesses and growth opportunities.

5. BUSINESS SEGMENTS

Previously, the Company reported results for the Chemicals segment, which consisted of the Polymer Emulsions business and the Polyurethane Intermediates (PUI) business. Beginning with the first quarter of 2008, the Polymer Emulsions business has been accounted for as discontinued operations as discussed in Note 2. Also beginning with the first quarter of 2008, the PUI business is reported as part of the Tonnage Gases segment and prior period information has been restated to reflect this business reorganization.

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

SUMMARY BY BUSINESS SEGMENTS

(Unaudited)

(Millions of dollars)

Three Months Ended

31 December

2007 2006

Revenues from external customers

Merchant Gases $897.0 $740.0

Tonnage Gases 791.1 689.5

Electronics and Performance Materials 514.3 486.9

Equipment and Energy 100.3 195.6

Healthcare 170.9 155.8

Segment and Consolidated Totals $2,473.6 $2,267.8

Operating income

Merchant Gases $175.4 $139.2

Tonnage Gases 111.1 95.4

Electronics and Performance Materials 66.0 49.8

Equipment and Energy 9.3 26.8

Healthcare 13.6 9.4

Segment Totals 375.4 320.6

Other (3.4) (3.2)

Consolidated Totals $372.0 $317.4

(Millions of dollars)

31 December 30 September

2007 2007

Identifiable assets (a)

Merchant Gases $4,175.6 $3,984.4

Tonnage Gases 3,391.4 3,328.4

Electronics and Performance Materials 2,425.0 2,435.3

Equipment and Energy 376.2 362.6

Healthcare 938.1 918.9

Segment Totals 11,306.3 11,029.6

Other 535.3 402.3

Discontinued operations 305.1 381.6

Consolidated Totals $12,146.7 $11,813.5

(a) Identifiable assets are equal to total assets less investments in and

advances to equity affiliates.


First Quarter Segment Performance

-- Merchant Gases sales of $897 million were up 21 percent and operating

income of $175 million increased 26 percent over the prior year on

higher volumes, improved pricing, a weaker dollar and productivity.

Margins increased to 19.6 percent, up 80 basis points versus the prior

year.

-- Tonnage Gases sales of $791 million were up 15 percent and operating

income of $111 million increased 16 percent over the prior year.

Revenues increased from higher volumes, increased natural gas costs and

a weaker dollar. The operating income increases were driven by higher

volumes, improved plant efficiencies and asset sales. These were

partially offset by planned maintenance costs for a number of plant

outages and higher bidding expenses related to the significant growth

opportunities in this segment.

-- Electronics and Performance Materials sales of $514 million were up six

percent and operating income of $66 million increased 33 percent over

the prior year on improved volumes. Electronics sales were driven by

higher specialty materials and bulk gas volumes, while Performance

Materials volume gains were driven by demand for surfactants and

specialty additives used in environmentally friendly formulations.

Margins increased significantly to 12.8 percent, a 260 basis point

improvement over the prior year, reflecting the impact of restructuring

actions in Electronics and increased sales of formulated products in

Performance Materials.

-- Equipment and Energy sales of $100 million and operating income of $9

million decreased from the prior year, as expected. The company

received one new LNG heat exchanger order during the quarter.

-- Healthcare sales of $171 million were up 10 percent and operating

income of $14 million increased 45 percent over the prior year, driven

by volume growth and lower costs in Europe.

Outlook

McGlade said, "Economic activity through the first quarter of this year is tracking in line with our expectations. Looking forward, we expect high bidding activity and solid demand from our customers, who rely on our products and services to improve energy efficiency, plant productivity, product quality and environmental performance.

"We believe the actions we have taken over the past few years have transformed us into a high performing company that is positioned to produce strong results in a slowing economic environment. Our focus on growth markets and geographies, productivity and streamlined operations, combined with a robust backlog of projects, should allow us to consistently deliver higher growth and higher returns in both the short and long-term.

"We are now expecting 15 to 19 percent* year-on-year earnings growth and, therefore, are raising our guidance."

The EPS guidance provided at the end of fiscal 2007 was $4.80 to $5.00, which included $0.17 of income for polymers for the full year and a $0.07 charge for pension settlements. Excluding these items, the underlying guidance was $4.70 to $4.90. On the same basis, the company is now forecasting a range of $4.85 to $5.00 for the year and $1.17 to $1.21 for the fiscal second quarter.

Annual Meeting of Shareholders

Air Products will host its Annual Meeting of Shareholders on Thursday, January 24, 2008 at 2:00 p.m. EST. Access the audio Webcast at: http://www.airproducts.com/Invest/shareholdersvcs/annualmeeting_materials.htm.

Air Products (NYSE: APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products has annual revenues of $10 billion, operations in over 40 countries, and 22,000 employees around the globe. For more information, visit http://www.airproducts.com.

***NOTE: This release contains "forward-looking statements" within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's reasonable expectations and assumptions as of the date of this presentation regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation, overall economic and business conditions different than those currently anticipated; future financial and operating performance of major customers and industries served by Air Products; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory activities; consequences of acts of war or terrorism impacting the United States' and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to portfolio management and cost reduction actions; the success of implementing cost reduction programs and achieving anticipated acquisition synergies; the timing, impact and other uncertainties of future acquisitions or divestitures; unanticipated contract terminations or customer cancellation or postponement of sales; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the impact of new or changed tax and other legislation and regulations in jurisdictions in which Air Products and its affiliates operate; the impact of new or changed financial accounting standards; and the timing and rate at which tax credits can be utilized. The company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this presentation to reflect any change in the company's assumptions, beliefs or expectations or any change in events, conditions or circumstances upon which any such forward- looking statements are based.

The presentation of non-GAAP measures is intended to enhance the usefulness of financial information by providing measures which the Company's management uses internally to evaluate the Company's baseline performance. Presented below is a reconciliation of reported GAAP results to non-GAAP measures.

CONSOLIDATED RESULTS Continuing Operations

Diluted EPS

Q2 YTD

2007 GAAP $4.50

Gain on contract settlement (.11)

Global cost reduction plan .04

Pension settlement .03

Donation/sale of cost investment (.09)

Tax audit settlements/adjustments (.17)

2007 Non-GAAP Measure $4.20

2008 Forecast GAAP $1.09-$1.13 $4.76-$4.91

Pension settlement .08 .09

2008 Forecast Non-GAAP $1.17-$1.21 $4.85-$5.00

2008 Forecast GAAP $4.76-$4.91

2007 GAAP $4.50

% Change GAAP 6%-9%

2008 Forecast Non-GAAP $4.85-$5.00

2007 Non-GAAP $4.20

% Change Non-GAAP 15%-19%

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

CONSOLIDATED INCOME STATEMENTS

(Unaudited)

(Millions of dollars, except for share data)

Three Months Ended

31 December

2007 2006

SALES $2,473.6 $2,267.8

COSTS AND EXPENSES

Cost of sales 1,788.5 1,649.7

Selling and administrative 296.8 275.4

Research and development 30.3 32.1

Pension settlement 1.4 --

Other (income) expense, net (15.4) (6.8)

OPERATING INCOME 372.0 317.4

Equity affiliates' income 25.3 27.3

Interest expense 41.0 39.1

INCOME FROM CONTINUING OPERATIONS BEFORE TAXES

AND MINORITY INTEREST 356.3 305.6

Income tax provision 93.2 79.5

Minority interest in earnings of subsidiary

companies 6.1 5.1

INCOME FROM CONTINUING OPERATIONS 257.0 221.0

INCOME FROM DISCONTINUED OPERATIONS, net of tax 6.7 9.3

NET INCOME $263.7 $230.3

BASIC EARNINGS PER COMMON SHARE

Income from continuing operations $1.20 $1.02

Income from discontinued operations 0.03 0.04

Net Income $1.23 $1.06

DILUTED EARNINGS PER COMMON SHARE

Income from continuing operations $1.16 $0.99

Income from discontinued operations 0.03 0.04

Net Income $1.19 $1.03

WEIGHTED AVERAGE OF COMMON

SHARES OUTSTANDING (in millions) 214.8 216.7

WEIGHTED AVERAGE OF COMMON

SHARES OUTSTANDING ASSUMING

DILUTION (in millions) 222.3 223.4

DIVIDENDS DECLARED PER

COMMON SHARE - Cash $.38 $.34

Other Data from Continuing Operations:

Capital Expenditures $273.3 $234.2

Depreciation and Amortization $218.0 $192.1

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Millions of dollars)

31 December 30 September

2007 2007

ASSETS

CURRENT ASSETS

Cash and cash items $96.5 $40.5

Trade receivables, less allowances for

doubtful accounts 1,667.5 1,578.5

Inventories and contracts in progress 732.2 746.2

Prepaid expenses 61.3 108.2

Other receivables and current assets 197.8 240.1

Current assets of discontinued operations 108.5 144.9

TOTAL CURRENT ASSETS 2,863.8 2,858.4

INVESTMENTS IN NET ASSETS OF AND ADVANCES

TO EQUITY AFFILIATES 791.6 778.1

PLANT AND EQUIPMENT, at cost 14,910.2 14,600.3

Less accumulated depreciation 8,209.9 7,996.6

PLANT AND EQUIPMENT, net 6,700.3 6,603.7

GOODWILL 1,236.6 1,199.9

INTANGIBLE ASSETS, net 282.4 276.2

OTHER NONCURRENT ASSETS 867.0 638.6

NONCURRENT ASSETS OF DISCONTINUED OPERATIONS 272.6 304.6

TOTAL ASSETS $13,014.3 $12,659.5

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES

Payables and accrued liabilities $1,502.3 $1,550.9

Accrued income taxes 103.6 108.6

Short-term borrowings and current portion

of long-term debt 559.8 694.4

Current liabilities of discontinued operations 58.9 68.8

TOTAL CURRENT LIABILITIES 2,224.6 2,422.7

LONG-TERM DEBT 3,415.6 2,976.5

DEFERRED INCOME & OTHER NONCURRENT LIABILITIES 842.7 872.0

DEFERRED INCOME TAXES 735.3 705.6

NONCURRENT LIABILITIES OF DISCONTINUED

OPERATIONS 9.6 9.8

TOTAL LIABILITIES 7,227.8 6,986.6

Minority interest in subsidiary companies 99.3 92.9

Minority interest of discontinued operations 84.2 84.4

TOTAL MINORITY INTEREST 183.5 177.3

TOTAL SHAREHOLDERS' EQUITY 5,603.0 5,495.6

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $13,014.3 $12,659.5

AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Millions of dollars)

Three Months Ended

31 December

2007 2006

OPERATING ACTIVITIES FROM CONTINUING OPERATIONS

Net Income $263.7 $230.3

Income from discontinued operations,

net of tax (6.7) (9.3)

Income from Continuing Operations 257.0 221.0

Adjustments to reconcile income to cash provided

by operating activities:

Depreciation and amortization 218.0 192.1

Deferred income taxes 20.8 15.3

Undistributed earnings of unconsolidated

affiliates (7.2) (13.8)

Gain on sale of assets and investments (6.2) (0.3)

Share-based compensation 17.1 16.6

Noncurrent capital lease receivables (47.7)
'/>"/>

SOURCE Air Products
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Makers of OTC Cough Medicines Reaffirm Efficacy of Products
2. DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs
3. Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
4. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
5. U.S. Food Safety: A Grocery List of Tainted Products
6. Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
7. Align Technology Previews New Invisalign Products at JPMorgan Healthcare Conference
8. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
9. Stress reduction products and services that are effective and safe
10. New ingredients in drug-like anti-aging products improve skin
11. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... ... prolapse with the latest techniques and the most minimally invasive approaches. , Women ... prolapse, particularly after menopause. Other risk factors include surgery to the pelvic floor, ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... program. MyDecision™ empowers employers and organizations with the tools and information to lower ... three elements to cut the cost of providing employee healthcare benefits by as ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT: ... world with an estimated 5000 perioperative nurses in attendance to study the ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016  Redwood Scientific Technologies, Inc. announced ... designed to help women balance their hormones. This product ... Jason Cardiff , President and CEO. ... to help the millions of women across the country ... of imbalanced hormones. Our research and development team is ...
(Date:2/5/2016)... , Feb. 5, 2016  Patients in Alabama ... focused ultrasound (HIFU) therapy no longer have to travel out ... its partnership with Urology Centers of Alabama to ... FDA-cleared procedure for qualifying patients. Alabama ... in the treatment of prostate cancer using many different modalities. ...
(Date:2/5/2016)... 5, 2016  Venice,s newest laser clinic, ... of its kind in the area and specializes ... laser treatment. The physician-owned and operated laser clinic ... by storm with its revitalizing skin care approach, ... Astanza Trinity technology. http://photos.prnewswire.com/prnh/20160204/329957 ...
Breaking Medicine Technology: